Zimmer Biomet’s Q2 Earnings Surge: Unrelenting Demand Fuels Profit Growth
Zimmer Biomet Holdings Inc. has reported a 7% surge in Q2 earnings, driven by strong demand for its hip and knee implants and medical devices, exceeding analyst expectations and solidifying its position as a leader in the medical device market.
2 minutes to read